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Thyroid hormones (TH) function in brain has been known for a very long time. In 1813,
Jean-François Coindet, a Swiss physician, made the discovery that iodine was efficient at treating
goiter and cretinism, a disease associated to mental retardation, which was endemic in his country.
This started a persisting tradition of research, which first identified TH [first thyroxine (T4) and
then 3,5,30-tri-iodo--thyronine) (T3)] as the active iodinated compounds, which early deficiency
explained cretinism. It also revealed a number of other functions for TH, not only during devel-
opment but also in adult brain. It is now well established that most brain cell types need TH for a
proper and timely differentiation. What makes the situation in brain different than in other organs
is that the consequences of TH deficiency become quickly irreversible. After the elucidation of the
corresponding signaling pathway, and the identification of the two genes, now called THRA and
THRB, which encode the nuclear receptors of T3 (TRs, including TRα1, TRβ1, and TRβ2), one
would expect that this research field would eventually run out of unsolved mysteries. This is far
from being the case and it seems that new questions keep arising all the time. This special issue is a
snapshot on some of current hot topics, which bring a stimulating overview of the current situation.
One key aspect of the neurodevelopmental function of TH, bringing major complications, is
that TH does not freely circulate in all brain areas and cell types, as originally postulated. TH
signaling seems therefore to be heterogeneous and dynamic in brain. First of all, local metabolism
by deiodinases can modulate the availability of TH. This has been exemplified in anterior cortex
(1), and studied in details in inner ear (2). Second, specific transporters play a major role for the
distribution of TH. Therefore, although most brain cells possess at least one of the TR, the levels
of TH in serum provide little indication for the TH-signaling level in different brain areas. The
physiopathological relevance of the question of TH transport in brain is best illustrated by the
Allan–Herndon–Dudley syndrome, a devastating genetic disease because of a genetic mutation in
MCT8, a gene encoding one of the TH transporters (3). Schroeder and Privalsky provide a clear
introduction to this difficult question, which involves local metabolism of TH by deiodinases, and
specific transporters required for TH to cross the blood–brain barrier or to reach the cell nucleus
(4). Anticipating recent reports for the importance of non-genomic pathways for TH signaling
in brain (5) they raise the hypothesis that T4 itself may be more than a prohormone, having a
function different from T3 in some situations. They also explain that differential expression of
coregulators may modulate TH signaling during development, a possibility that has not yet been
extensively explored (6, 7). Muller and Heuer (8) provide a novel and extensive description of the
main TH transporters expression patterns in mice. These new data confirm that the transporter
can potentially generate a very heterogeneous distribution of TH in brain. Wirth et al. (9) provide
a comprehensive overview of the growing knowledge on TH transporters in brain, in various
vertebrate models. They also discuss the possibility that other iodinated compounds, which are
also transported in brain, may have a neglected function, independent of the classical TR pathway.
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Although neurons are the primary target of T3 actions,most of the
T3 present in brain is made by T4 deiodination, which takes place
predominantly, if not exclusively, in glial cells: the tanycytes lining
part of the third ventricle surface and in the astrocytes throughout
the brain. Morte and Bernal (10) show that how the combination
of primary cell cultures, genome-wide expression analysis, and
mouse genetics recently revealed a dynamic evolution of this
astrocytes–neurons dialog during neurodevelopment. This also
led to the puzzling conclusion that the source of T3 matters: some
genes, which expression is down-regulated by T3, would respond
differently, depending on whether T3 crossed the brain–blood
barrier, or was produced by local deiodination of T4. A general
picture emerges, where TH become much more than a trophic
factor, their tightly regulated distribution providing positional
information to the developing neurons.
The neurodevelopmental consequences of altered TH signaling
have been studied in great details over the years. Cerebellum
proved to be a brain area suitable for in-depth investigation in
rodent models. The first advantage, compared to other brain
areas, is its relatively simple neuroanatomy, which few main
cell types. The other is that its maturation takes place at a late
stage of brain development, within the first post-natal weeks in
rodent, when the circulating level of TH is normally high. This
probably explains why the histological consequences of early TH
deficiency are particularly dramatic in this brain area. Faustino
and Ortiga-Carvalho review the recent progresses in our under-
standing in the way TH coordinate cellular interactions during
this process, and the limited knowledge that we have on TRα1
and TRβ1 target genes in this promising model (11). In an ambi-
tious reflection, Berbel et al. (12) generalize these concepts to
cortex development, carefully discussing the relevance of rodent
models to human pathology, and placing animal studies in an
evolutionary perspective. In-depth examination of T3 regulated
genes reveals hidden connection between TH deficiency and
major neurodevelopmental diseases: epilepsy, autism, attention
deficit hyperactive disorder, and schizophrenia. This landmark
review should have far reaching consequences for later investiga-
tions, as it outlines that T3 is an essential timer of brain devel-
opment, and that any alteration in T3 signaling has long-term
consequences on neurological and cognitive functions. Remaud
et al. (13) show that TH neurodevelopmental functions in brain
do not stop after maturation, but persist throughout life, as the
differentiation of adult neural stem cells, present in the hip-
pocampus and the subventricular zone, also depends on TH. This
leads to the proposal that the known decline of TH levels upon
aging, may partially explain several adverse effects on cognitive
functions.
One site in the adult brain where TH has been proved to
exert a number of important functions is the hypothalamus. This
is especially important because hypothalamus is a brain area,
which communicates with peripheral organs and a place where
many physiological processes can cross-talk. Some TH functions,
which are thought to involve peripheral organs, may actually
stem in the hypothalamus. One important example is that the
control of energy homeostasis, originally believed to result from
direct stimulation of liver, muscles, white, and brown adipose
tissue. It is now demonstrated that this important function of
TH also involves the hypothalamus, which secretes a number
of signaling peptides and set the sympathetic tone (14). Three
reviews focus on one hypothalamic function of TH, which is
an area of intense investigations: the involvement of TH in the
so-called seasonal clock, which allow many animal species to
reproduce at a specific season. Using a fish model, Ogawa et al.
present new data showing that TH can activate, directly or indi-
rectly, the expression of Kiss2 and Gnrh genes in hypothalamus,
which are important upstream effectors of the gonadotrophic
axis (15). Shinomiya et al. explain how initial studies of the
photoperiodic change in gene expression in hypothalamus, per-
formed in quail by the Nagoya group, led to the discovery
of a general mechanism, common to vertebrate, which allow
to couple the seasonal change in day length and reproduction
(16). Dardente et al. highlight several missing links in this gen-
eral model, which suggest that important contributions are still
ahead (17).
All these contributions provide a timely update of an abundant
literature, and suggest exciting avenues for new investigations.
These will also be stimulated by new questions raised by the dis-
covery of new genetic diseases altering TH signaling in brain (18)
and by the concern that some environmental contaminants acting
as TH disruptors might compromise normal brain development
(19). Most of all, as TH act primarily on gene expression, studies
of TH function in brain will continue to provide an outstand-
ing opportunity to explore the basic genetic mechanisms, which
govern neurodevelopment and adult brain functions.
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